FMTX - Forma Therapeutics Holdings Inc. (FMTX) CEO Frank Lee on Q3 2021 Results - Earnings Call Transcript
Forma Therapeutics Holdings, Inc. (FMTX) Q3 2021 Earnings Conference Call November 12, 2021 08:00 AM ET Company Participants Mario Corso - Senior Director of IR Frank Lee - President and CEO Pat Kelly - Chief Medical Officer Dave Cook - Chief Scientific Officer Todd Shegog - CFO Conference Call Participants Mark Breidenbach - Oppenheimer Maury Raycroft - Jefferies Alethia Young - Cantor Fitzgerald Robin Garner - Craig-Hallum Presentation Operator Good morning. Welcome to the Forma Therapeutics Third Quarter 2021 Financial Results and Business Update Conference Call. All participants are currently in a listen-only mode. Following management’s prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this call is being recorded today, November 12, 2021. I would now like to turn the conference over to Mario Corso. Please go ahead sir. Mario Corso Thank you, operator. This is Mario Corso, Senior Director of Investor Relations at Forma.
For further details see:
Forma Therapeutics Holdings, Inc. (FMTX) CEO Frank Lee on Q3 2021 Results - Earnings Call Transcript